Prostate cancer screening at National Cancer Institute comprehensive and clinical cancer centers.

Suppr

超能文献

作者信息

Taylor Kathryn L, Africano Nicole L, Schwartz Marc, Cullen Jennifer, Ahaghotu Chiledum

出版信息

J Natl Cancer Inst. 2004 Mar 3;96(5):414-5. doi: 10.1093/jnci/djh073.

DOI:10.1093/jnci/djh073

PMID:14996868

Abstract

摘要

相似文献

Prostate cancer screening at National Cancer Institute comprehensive and clinical cancer centers.

J Natl Cancer Inst. 2004 Mar 3;96(5):414-5. doi: 10.1093/jnci/djh073.

Prostate cancer: numbers may not tell the whole story.

J Natl Cancer Inst. 2000 Dec 6;92(23):1873-6. doi: 10.1093/jnci/92.23.1873.

Risks of PSA screening now better understood.

J Natl Cancer Inst. 2013 Nov 6;105(21):1590-2. doi: 10.1093/jnci/djt328. Epub 2013 Oct 18.

Uninformed compliance or informed choice? A needed shift in our approach to cancer screening.

J Natl Cancer Inst. 2011 Dec 21;103(24):1821-6. doi: 10.1093/jnci/djr474. Epub 2011 Nov 21.

Screening for prostate cancer: informing men about their options.

Clin J Oncol Nurs. 2005 Oct;9(5):625-7. doi: 10.1188/05.CJON.625-627.

Counseling Patients About Prostate Cancer Screening.

Am Fam Physician. 2018 Oct 15;98(8):478-483.

The National Cancer Institute Multi-Screening Trial.

Can J Oncol. 1994 Nov;4 Suppl 1:98-9; discussion 100-1.

Balancing the benefits and risks of choice.

Lancet. 2016 Sep 17;388(10050):1129. doi: 10.1016/S0140-6736(16)31641-5. Epub 2016 Sep 16.

Editorial panel on informed consent for PSA screening.

Urology. 2003 Sep;62(3):589. doi: 10.1016/s0090-4295(03)00270-x.

[Informed consent for patients on early recognition of prostate carcinoma is insufficient].

Urologe A. 2009 Sep;48(9):997-8, 1000-1. doi: 10.1007/s00120-009-2074-5.

引用本文的文献

Lack of comprehension of common prostate cancer terms in an underserved population.

J Clin Oncol. 2009 Apr 20;27(12):2015-21. doi: 10.1200/JCO.2008.17.3468. Epub 2009 Mar 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Prostate cancer screening at National Cancer Institute comprehensive and clinical cancer centers.

J Natl Cancer Inst. 2004 Mar 3;96(5):414-5. doi: 10.1093/jnci/djh073.

Prostate cancer: numbers may not tell the whole story.

J Natl Cancer Inst. 2000 Dec 6;92(23):1873-6. doi: 10.1093/jnci/92.23.1873.

Risks of PSA screening now better understood.

J Natl Cancer Inst. 2013 Nov 6;105(21):1590-2. doi: 10.1093/jnci/djt328. Epub 2013 Oct 18.

Uninformed compliance or informed choice? A needed shift in our approach to cancer screening.

J Natl Cancer Inst. 2011 Dec 21;103(24):1821-6. doi: 10.1093/jnci/djr474. Epub 2011 Nov 21.

Screening for prostate cancer: informing men about their options.

Clin J Oncol Nurs. 2005 Oct;9(5):625-7. doi: 10.1188/05.CJON.625-627.

Counseling Patients About Prostate Cancer Screening.

Am Fam Physician. 2018 Oct 15;98(8):478-483.

The National Cancer Institute Multi-Screening Trial.

Can J Oncol. 1994 Nov;4 Suppl 1:98-9; discussion 100-1.

Balancing the benefits and risks of choice.

Lancet. 2016 Sep 17;388(10050):1129. doi: 10.1016/S0140-6736(16)31641-5. Epub 2016 Sep 16.

Editorial panel on informed consent for PSA screening.

Urology. 2003 Sep;62(3):589. doi: 10.1016/s0090-4295(03)00270-x.

[Informed consent for patients on early recognition of prostate carcinoma is insufficient].

Urologe A. 2009 Sep;48(9):997-8, 1000-1. doi: 10.1007/s00120-009-2074-5.

引用本文的文献

Lack of comprehension of common prostate cancer terms in an underserved population.

J Clin Oncol. 2009 Apr 20;27(12):2015-21. doi: 10.1200/JCO.2008.17.3468. Epub 2009 Mar 23.